Luxfer (LXFR) Investor presentation summary

Financial performance and highlights

• Adjusted sales for FY 2025 reached $371.2M, up 2.5% YoY, with adjusted EBITDA of $51.9M and a margin of 14.0%.

• Adjusted EPS for 2025 was $1.11, a 12.1% increase from the prior year, and free cash flow totaled $26.2M.

• Elektron segment sales grew 11.6% to $196.4M, with adjusted EBITDA up 16.0% to $36.9M and margins near 19%.

• Gas Cylinders segment sales declined 6.2% to $174.8M, with adjusted EBITDA down 16.7% to $15.0M, but operational efficiencies supported margins.

• Pricing actions and FX provided a $2.7M benefit in Q4, offsetting volume/mix headwinds, especially in automotive and clean energy.

Operational and strategic initiatives

• Continued optimization of manufacturing footprint, including consolidation of sites and capacity improvements.

• Focus on core businesses in defense, aerospace, and specialty industrial markets, with strong technical positions.

• Lean execution and automation initiatives drove cost control and efficiency gains.

• Board is actively exploring strategic alternatives to maximize long-term shareholder value.

• Maintained strong balance sheet flexibility, with net debt/EBITDA at 0.6x.

Segment and product platform overview

• Elektron specializes in magnesium alloys, zirconium solutions, and advanced chemical formulations for high-value defense and aerospace applications.

• Gas Cylinders focuses on lightweight, high-pressure storage for aerospace, medical, and industrial uses, with proprietary safety and efficiency technologies.

• Both segments leverage proprietary technologies and long-standing OEM partnerships to support recurring revenue and new product cycles.